Header cover image

Pharmaceuticals & Biotech Biotech Breakthroughs

Results

6

0 new

Companys with strong funding and high growth potential

6 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

S1GE34

Seagen		US$56.706.7%n/aUS$43.2bUS$56.74PS18.8xE71.8%n/a

A1RG34

argenx		€115.87-1.6%15.3%€28.5b€124.17PS19.2xE58.4%n/a

I2TC34

Intra-Cellular Therapies		US$69.27-2.6%n/aUS$7.9bUS$90.96PS13.7xE64.4%n/a

B1GN34

BeiGene		US$45.653.8%17.4%US$22.0bUS$58.88PS7.3xE64.1%n/a

VRTX34

Vertex Pharmaceuticals		US$628.74-1.8%43.8%US$119.5bUS$692.09PS11.6xE46.4%n/a

R2GE34

Repligen		US$27.00-1.7%n/aUS$8.2bUS$35.56PS13.7xE85.3%n/a
Page 1 of 1
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.